Skip to main
IEX

IDEX (IEX) Stock Forecast & Price Target

IDEX (IEX) Analyst Ratings

Based on 7 analyst ratings
Buy
Strong Buy 57%
Buy 29%
Hold 14%
Sell 0%
Strong Sell 0%

Bulls say

IDEX is projected to achieve a core sales increase of 1.5% to 2% in 2026, reflecting strong order growth of 7%, particularly in sectors such as data centers, municipal water, and semiconductor maintenance, repair, and operations (MRO). The company reported organic revenue growth of 5% in 2025, surpassing estimates, driven by robust performance in the Fluid and Metering Technologies (FMT) and Health and Science Technologies (HST) segments. Positive indications for future growth are supported by anticipated increases in core sales of 3% to 4% for 2027, stemming from optimistic outlooks in niche markets including pharmaceuticals and space defense.

Bears say

IDEX exhibits a concerning financial outlook characterized by mixed organic sales and order trends across its segments, indicating potential stagnation in revenue growth. The company's gross debt/EBITDA ratio stands at 2.0x, suggesting manageable leverage, yet the persistent exposure to cyclical markets raises concerns about the sustainability of its performance in light of economic uncertainties. Additionally, projections indicate a potential cash EPS of only ~$7.61 for 2026, highlighting vulnerability to prolonged revenue declines and operating margin pressures, which could further hinder IDEX's financial stability.

IDEX (IEX) has been analyzed by 7 analysts, with a consensus rating of Buy. 57% of analysts recommend a Strong Buy, 29% recommend Buy, 14% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of IDEX and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About IDEX (IEX) Forecast

Analysts have given IDEX (IEX) a Buy based on their latest research and market trends.

According to 7 analysts, IDEX (IEX) has a Buy consensus rating as of Mar 25, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $228.86, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $228.86, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

IDEX (IEX)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.